ACM
CLB icon

Arosa Capital Management’s Core Laboratories CLB Stock Holding History

Arosa Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-110,000
Closed -$1.68M – 79
2020
Q3 		$1.68M Buy
+110,000
New +$2.31M 0.26% 57
2018
Q3 		– Sell
-109,458
Closed -$13.8M – 62
2018
Q2 		$13.8M Sell
109,458
-66,792
-38% -$8.13M 1.8% 22
2018
Q1 		$19.1M Buy
+176,250
New +$19.5M 2.65% 13

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arosa Capital Management's CLB Position: Q4 2020 in Review

Arosa Capital Management sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 110,000 shares — an estimated $1.68M sold.

Arosa Capital Management first reported a position in CLB in Q1 2018 and held it in 3 quarters. The position peaked at $19.1M in Q1 2018. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Arosa Capital Management reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Arosa Capital Management sold 110,000 Core Laboratories shares in Q4 2020, an estimated $1.68M.
  • Arosa Capital Management first reported a position in Core Laboratories in Q1 2018 and held it in 3 quarters.
  • Arosa Capital Management's Core Laboratories position peaked at $19.1M in Q1 2018.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Arosa Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.